 |
Ritalin studied for Cancer Risk |
Washington, D.C. (AHN) - A study into Ritalin and other stimulant drugs for children will be conducted to determine whether these drugs increase the risk of cancer in later life.
A recent University of Texas and M.D. Anderson Cancer Center study found damage to the chromosomes of 12 children who took Ritalin for three months.
The advisory committee had been called to discuss yet another health issue surrounding the class of ADHD medications known as methylphenidates, to which Ritalin belongs: Some psychiatric side effects have been reported among children using Concerta, Ritalin and other versions of these drugs.
A team of experts from the U.S. Food and Drug Administration, the National Institutes of Health and the Environmental Protection Agency went to Texas last month to examine the methods used in the study.
Despite flaws in the study's methodology, its results could not be dismissed, therefore launching plans for further insights. Other scientists caution the study was far too small and its finding far too preliminary to cause alarm.
Is a Safe Non-Drug Nutrient Available in the US?
